思路迪医药股份有限公司（股票代码：01244）于2026年8月6日发布截至2026年7月31日的月度股份变动报告。报告显示，公司注册股本为500,000港元（面值每股0.001港元），期末仍维持该规模未发生任何增减变动。
根据报告，思路迪医药股份于7月末的已发行股份总数为258,177,000股，均为普通股，较上月底保持不变，且无持作库藏的股份。期间公司未开展任何新增发行、回购或注销活动；股权激励方面，7月末公司共计拥有12,802,850份尚可行使的股份期权，上月无新增股份期权授予、行使或失效情况。
此外，公司符合香港联交所关于最低公众持股量的相关要求。公司声明所有股票发行及库藏股份变动均已获得董事会正式授权，符合上市规则及相关法律法规。公告由董事龚兆龙签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.